KILITCH DRUGS (INDIA)
Back to Balance Sheet
|
KILITCH DRUGS (INDIA) Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹453 Cr | ₹310 Cr | ₹237 Cr | ₹218 Cr | ₹208 Cr |
What is the latest Total Liabilities ratio of KILITCH DRUGS (INDIA) ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹453 Cr |
| Mar2025 | ₹310 Cr |
| Mar2024 | ₹237 Cr |
| Mar2023 | ₹218 Cr |
| Mar2022 | ₹208 Cr |
How is Total Liabilities of KILITCH DRUGS (INDIA) Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹453 Cr | 46.23 | |
| Mar2025 | ₹310 Cr | 30.49 | |
| Mar2024 | ₹237 Cr | 9.17 | |
| Mar2023 | ₹218 Cr | 4.42 | |
| Mar2022 | ₹208 Cr | - | |
Compare Total Liabilities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹771.1 Cr | 3.3% | 28.1% | 25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 3.3% |
28.1% |
25.8% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses